Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $139.65 USD
Change Today +0.04 / 0.03%
Volume 952.3K
SIAL On Other Exchanges
As of 5:20 PM 10/9/15 All times are local (Market data is delayed by at least 15 minutes).

sigma-aldrich (SIAL) Snapshot

Previous Close
Day High
Day Low
52 Week High
05/29/15 - $140.03
52 Week Low
10/16/14 - $132.45
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for SIGMA-ALDRICH (SIAL)

sigma-aldrich (SIAL) Related Businessweek News

No Related Businessweek News Found

sigma-aldrich (SIAL) Details

Sigma-Aldrich Corporation, a life science and high technology company, develops, manufactures, purchases, and distributes various chemicals, biochemicals, and equipment products worldwide. The company provides chemical products, reagents, and kits and services are used in scientific research, including genomic and proteomic research, biotechnology, pharmaceutical development, and diagnosis of disease; and as key components in pharmaceutical, diagnostics, and high technology manufacturing. It offers media and critical raw materials for industrial cell culture, contract manufacturing services, pharmaceutical safety testing services, and organometallic precursors for semiconductor manufacturing. The company sells its products to pharmaceutical companies, universities, commercial laboratories, industrial companies, biotechnology companies, non-profit organizations, governmental institutions, diagnostic, chemical and electronics companies, and hospitals. Sigma-Aldrich Corporation was founded in 1951 and is based in St. Louis, Missouri.

9,700 Employees
Last Reported Date: 07/30/15
Founded in 1951

sigma-aldrich (SIAL) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $1.0M
Chief Financial Officer and Executive Vice Pr...
Total Annual Compensation: $485.4K
Executive Vice President and President of App...
Total Annual Compensation: $455.7K
Executive Vice President and President of SAF...
Total Annual Compensation: $404.2K
Compensation as of Fiscal Year 2014.

sigma-aldrich (SIAL) Key Developments

Sigma-Aldrich Corporation Announces Exclusive Distribution Agreement with IROA Technologies LLC

Sigma-Aldrich Corporation announced that it has signed an exclusive global distribution agreement with IROA Technologies, LLC to distribute IROA's Mass Spectrometry Metabolite Library of Standards™ (MSMLS). The agreement partners IROA's MSMLS product portfolio and software with the eCommerce and supply chain capabilities of Sigma-Aldrich. MSMLS is a collection of high-quality small molecules that span a broad range of primary metabolism. These are high purity (>95%) compounds supplied in an economical, ready-to-use format. The library of standards is most commonly used to provide retention times and spectra for key metabolic compounds, help optimize mass spectrometry analytical protocols and qualify and quantify mass spectrometry sensitivity and limit of detection. Under the agreement, Sigma-Aldrich has worldwide rights to sell IROA Technologies' Mass Spectrometry Metabolite Library of Standards. Sigma-Aldrich will employ its sales, marketing and eCommerce expertise and leverage the strength of its relationships with the scientific community to present and distribute MSMLS and the corresponding software, MSMLSDiscovery™.

Cerilliant Introduces New Multi-Component Reference Solutions for Drug Interference Testing

Sigma-Aldrich Corporation announced that the Cerilliant® brand within its Applied Diagnostics and Testing business segment now offers the first-ever reference solutions for qualitative evaluation of drug interferences in a testing laboratory's analytical methods. These seven multi-component solution mixes contain more than 50 of the most routinely monitored over-the-counter (OTC) and prescription drugs. Cerilliant offers the seven mixes separately or as a kit for added convenience. Regulations for drug bioanalysis, including the Clinical Laboratory Improvement Amendments (CLIA), as well as the US FDA Bioanalytical Method Validation Guidance, state that manufacturers of laboratory-developed tests (LDTs) must determine the effect of interfering substances during design, development, and validation of an analytical method. The presence of interfering substances, which often includes drugs and their metabolites, impacts measurement accuracy of the analyte of interest. Interfering compounds originate from many sources including sample matrix, contaminants inadvertently introduced during handling or sample preparation, and samples from patients on multiple drug regimens. The importance of identifying interfering substances is critical for numerous testing applications ranging from therapeutic drug monitoring (TDM), confirmatory drug testing, and forensic analysis to bioavailability (BA)/bioequivalence (BE) and pharmacokinetic (DMPK) studies.

Sigma-Aldrich Corporation Announces Agreement with Public Health England to Manufacture and Supply NCTC/NCPF Certified Reference Materials

Sigma-Aldrich Corporation announced it has signed an agreement with Public Health England to manufacture and supply bacterial and fungal NCTC/NCPF Certified Reference Materials in LENTICULE disc format worldwide for use as controls in food, water, environmental and clinical testing microbiology laboratories. Each CRM LENTICULE disc consists of a stipulated level of a pure culture of viable bacteria or fungi in a control-dried water-soluble matrix. The bacterial and fungal strains are prepared directly from strains selected from PHE's National Collection of Type Cultures and National Collection of Pathogenic Fungi.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SIAL:US $139.65 USD +0.04

SIAL Competitors

Market data is delayed at least 15 minutes.

Company Last Change
CR Bard Inc $186.71 USD -0.31
Dr Reddy's Laboratories Ltd 4,258 INR +32.65
Illumina Inc $147.77 USD +7.40
Symrise AG €56.92 EUR +0.92
UCB SA €68.48 EUR +0.34
View Industry Companies

Industry Analysis


Industry Average

Valuation SIAL Industry Range
Price/Earnings 34.7x
Price/Sales 6.1x
Price/Book 5.1x
Price/Cash Flow 34.3x
TEV/Sales 5.5x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SIGMA-ALDRICH, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at